We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the full press release to hear more on the partnership, and the three strategic platforms that CSL Behring is currently focusing...

Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee, commented: “In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team...

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion. Roivant Sciences reported in a press release that all existing institutional shareholders participated in the latest funding round....

For a data-backed opinion on Switzerland and Europe as a whole, we recommend the KPMG report “Site Selection for Life Sciences Companies in Europe”. It is loaded with stats about innovation scores, product pipelines, financing and more. For us it came as no surprise to...

The patent law and attorney-at-law firm Vossius & Partner has been an important partner for BaseLaunch since the inception of the healthcare accelerator in 2016. They advise startups and big corporations alike on IP strategy. Philipp Marchand, patent attorney in the Basel office, advocates to...

Protecting an invention is absolutely key and one of the first steps on the route towards commercializing promising research.  Additionally, where the IP is owned by the university hosting the inventor, in order for any investor to put real money into the company, one has...